Litcius/Paper detail

Dysregulation of the immune response in coronavirus disease 2019

Leila Mohamed Khosroshahi, Nima Rezaei

2020Cell Biology International54 citationsDOIOpen Access PDF

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can trigger a cytokine storm in the pulmonary tissue by releasing various types of mediators, leading to acute respiratory distress syndrome (ARDS). Increased neutrophil-to-lymphocyte ratio, as well as CD4+ T lymphopenia, is reported in cases with novel coronavirus disease (COVID-19), meanwhile, lymphopenia is a significant finding in the majority of COVID-19 cases with a severe phenotype. Moreover, excessive activation of monocyte/macrophage and cytokine storms are associated with the severity of the disease and the related complications in SARS-CoV-2 infection. Understanding the immune response dysregulation in COVID-19 is essential to develop more effective diagnostic, therapeutic, and prophylactic strategies in this pandemic.

Topics & Concepts

Cytokine stormARDSImmunologyImmune systemMedicineCoronavirusImmune dysregulationDiseaseCytokineLymphocyteMonocyteCoronavirus disease 2019 (COVID-19)PandemicMacrophage activation syndromeLungInfectious disease (medical specialty)Internal medicineArthritisCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research
Dysregulation of the immune response in coronavirus disease 2019 | Litcius